HSCS — HEART TEST LABORATORIES INC. COMMON STOCK (Healthcare >> Medical Devices)
HSCS FAQ
What is HSCS's ROE?
HEART TEST LABORATORIES INC. COMMON STOCK reports a Return on Equity (ROE) of -319.94%.
What is HSCS's dividend yield?
HEART TEST LABORATORIES INC. COMMON STOCK offers a dividend yield of 0.00%.
What is HSCS's Deepscope Quality Score?
Deepscope rates HSCS's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy HSCS?
Deepscope's AI Timing Score for HSCS is 1 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does HSCS belong to?
HEART TEST LABORATORIES INC. COMMON STOCK is classified under the Healthcare >> Medical Devices sector on the NASDAQ exchange.
|
USD 1.94
Price
-0.07
(-3.49%)
Day Change
|
|
|---|
HSCS, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
Growth of ROA was below our criteria in the last year.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.94 |
| PBV / Sector |
2.41 / 7.50
|
| Earning Per Share | -2.57 |
| PE / Sector |
N/A / 29.01
|
| PEG or PE/Growth / Sector |
N/A / 0.39
|
| Average 1M Daily Value |
0.06 M
GREAT
|
| Average 1W Daily Value |
0.12 M
GREAT
|
| Timing Factors |
|
42% |
| Financial Health |
|
43% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:46 |
| Symbol | HSCS |
| Name | HEART TEST LABORATORIES INC. COMMON STOCK |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 3.18 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 6.40 / 18,389.26 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 550 Reserve Street, Southlake, TX, United States, 76092
Phone: 682 237 7781
Website: https://heartsciences.com
Sector: Healthcare >> Medical Devices
Description: HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-based platform to host AI-ECG algorithms on an ECG hardware agnostic basis. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google